Multifunctional Tailorable Composite System As a Dual Peptide-Drug Delivery System
Arajo Francisca,Neha Shrestha,Gomes Maria,Dongfei Liu,Herranz-Blanco Brbara,Hirvonen Jouni,Granja Pedro,Santos Hlder,Bruno Sarmento
DOI: https://doi.org/10.3389/conf.fbioe.2016.01.02485
IF: 5.7
2016-01-01
Frontiers in Bioengineering and Biotechnology
Abstract:Event Abstract Back to Event Multifunctional tailorable composite system as a dual peptide-drug delivery system Francisca Araújo1, 2, 3, 4, Neha Shrestha4, Maria J. Gomes1, 2, 3, Dongfei Liu4, Bárbara Herranz-Blanco4, Jouni Hirvonen4, Pedro L. Granja1, 2, 3, Hélder A. Santos4 and Bruno Sarmento1, 2, 3, 5 1 i3S - Instituto de Investigação e Inovação em Saúde, Portugal 2 INEB - Instituto Engenharia Biomédica, Portugal 3 ICBAS - Instituto Ciências Biomédicas Abel Salazar, Portugal 4 Faculty of Pharmacy, University of Helsinki, Division of Pharmaceutical Chemistry and Technology, Finland 5 Instituto Superior de Ciências da Saúde-Norte, CESPU, INFACTS - Instituto de Investigação e Formação Avançada em Ciências e Tecnologias da Saúde, Portugal Introduction: The clinical use of glucagon like peptide-1 (GLP-1) is in the pipeline of type 2 diabetes Mellitus (T2DM) therapy. It acts in a glucose-dependent way stimulating insulin production[1]. However, its half-life time is less than 2 minutes due to its cleavage by the dipeptidyl peptidase 4 (DPP4) enzyme[1]. To achieve an efficient in vivo oral release and permeability of active GLP-1, GLP-1 was loaded into modified particles. Experimental Methods: Poly(lactic-co-glycolic acid) (PLGA) were modified with chitosan and a cell-penetrating peptide[2],[3]. Afterwards, GLP-1 loaded nanoparticles were encapsulated into a pH-sensitive polymer HPMCAS-MF, and loaded with DPP4 inhibitor, using a microfluidics technique. The system was then characterized. The in vivo tests were performed in a rat T2DM model, induced by conjugation of streptozotocin and nicotinamide, and the blood glucose levels, were quantified. The plasmatic insulin levels, as well as the pancreatic insulin content, were evaluated. Results and Discussion: The particles presented maintenance of their integrity at pH below 6.0. The release profiles showed that the enteric coating was successful, protecting the release of GLP-1 in acidic conditions, while in FaSSIF it reached 40% release after 6 h. The interaction between the NPs and the intestinal co-culture cells showed that there was a clear increase in the interaction between the modified NPs with the cells. The activity results of DPP4 enzyme after the contact with the inhibitor showed that its activity is extremely lower in comparison with cells without any contact with the inhibitor. In the in vivo assays, the blood glucose levels decreased after 4 hours of particles administration and kept low thereafter. The insulin levels increase along the time and the insulin pancreatic content was higher in the experimental groups in comparison with the control. Conclusion: The developed particles were sensitive to different pH, showing to be viable systems to interact in a closer way with intestinal cells. They allow the co-delivery of two drugs in a single formulation. The very low activity of DPP4 enzyme prolongs GLP-1’s half-life, thus increasing the insulin levels and decreasing the blood glucose levels along the time. This work had the financial support of FCT / MEC through National Funds and, when applicable, co-financed by the FEDER via the PT2020 Partnership Agreement under the 4293 Unit I&D.; F. Araújo thanks FCT for financial support (SFRH/BD/87016/2012).; Dr. H.A. Santos acknowledges financial support from the Academy of Finland (decision no. 252215), the University of Helsinki Research Funds, the Biocentrum Helsinki and the ERC project (no. 310892).References:[1] Araújo, F. et al., Curr. Pharm. Biotechnol. 15:609-19, 2014.[2] Araújo, F. et al. Biomaterials. 35:9199-207, 2014.[3] Araújo, F. et al,. ACS Nano. 9:8291-302, 2015. Keywords: Drug delivery, protein, Biocompatibility, delivery Conference: 10th World Biomaterials Congress, Montréal, Canada, 17 May - 22 May, 2016. Presentation Type: Poster Topic: Biomaterials for therapeutic delivery Citation: Araújo F, Shrestha N, Gomes MJ, Liu D, Herranz-Blanco B, Hirvonen J, Granja PL, Santos HA and Sarmento B (2016). Multifunctional tailorable composite system as a dual peptide-drug delivery system. Front. Bioeng. Biotechnol. Conference Abstract: 10th World Biomaterials Congress. doi: 10.3389/conf.FBIOE.2016.01.02485 Copyright: The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers. They are made available through the Frontiers publishing platform as a service to conference organizers and presenters. The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated. Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed. For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions. Received: 27 Mar 2016; Published Online: 30 Mar 2016. Login Required This action requires you to be registered with Frontiers and logged in. To register or login click here. Abstract Info Abstract The Authors in Frontiers Francisca Araújo Neha Shrestha Maria J Gomes Dongfei Liu Bárbara Herranz-Blanco Jouni Hirvonen Pedro L Granja Hélder A Santos Bruno Sarmento Google Francisca Araújo Neha Shrestha Maria J Gomes Dongfei Liu Bárbara Herranz-Blanco Jouni Hirvonen Pedro L Granja Hélder A Santos Bruno Sarmento Google Scholar Francisca Araújo Neha Shrestha Maria J Gomes Dongfei Liu Bárbara Herranz-Blanco Jouni Hirvonen Pedro L Granja Hélder A Santos Bruno Sarmento PubMed Francisca Araújo Neha Shrestha Maria J Gomes Dongfei Liu Bárbara Herranz-Blanco Jouni Hirvonen Pedro L Granja Hélder A Santos Bruno Sarmento Related Article in Frontiers Google Scholar PubMed Abstract Close Back to top Javascript is disabled. Please enable Javascript in your browser settings in order to see all the content on this page.